As of 2024-12-15, the Intrinsic Value of PureTech Health PLC (PRTC.L) is
29.58 GBP. This PRTC.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 162.80 GBP, the upside of PureTech Health PLC is
-81.80%.
The range of the Intrinsic Value is (25.19) - 48.14 GBP
29.58 GBP
Intrinsic Value
PRTC.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(25.19) - 48.14 |
29.58 |
-81.8% |
| DCF (Growth 10y) |
45.79 - (21.69) |
28.58 |
-82.4% |
| DCF (EBITDA 5y) |
59.72 - 27.09 |
42.47 |
-73.9% |
| DCF (EBITDA 10y) |
55.10 - 24.03 |
39.41 |
-75.8% |
| Fair Value |
-132.56 - -132.56 |
-132.56 |
-181.42% |
| P/E |
(941.14) - (1,044.53) |
(1,055.14) |
-748.1% |
| EV/EBITDA |
(429.41) - (609.49) |
(629.82) |
-486.9% |
| EPV |
(390.63) - (517.40) |
(454.01) |
-378.9% |
| DDM - Stable |
(312.21) - (1,141.07) |
(726.64) |
-546.3% |
| DDM - Multi |
(10.76) - (30.44) |
(15.88) |
-109.8% |
PRTC.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
401.27 |
| Beta |
2.21 |
| Outstanding shares (mil) |
2.46 |
| Enterprise Value (mil) |
175.87 |
| Market risk premium |
5.98% |
| Cost of Equity |
8.02% |
| Cost of Debt |
6.16% |
| WACC |
7.87% |